Multiple Sclerosis Center

Hadassah and Neurogenesis Announce Groundbreaking Results From Phase 2 MS Study

A Phase 2 study at Hadassah Hospital Ein Kerem has revealed significant clinical improvements in patients with progressive multiple sclerosis (MS) after being treated with NG-01 stem cells developed by…

British Patient Talks To The BBC About Searching For A Miracle Cure For MS At Hadassah

Jerusalem Marathon

Hadassah MS Patient Runs in the Jerusalem Marathon

MS Research

Malia’s 18-year Odyssey with MS–and Back to Life As She Knew It

Multiple Sclerosis Center

Hadassah Shares Breakthroughs at Annual World Stem Cell Summit

Multiple Sclerosis Center

Being a Patient at Hadassah: Aly’s Blog

MS Research

“Stunning Results” Continue with Hadassah’s Stem Cell Treatment to Reverse MS

Multiple Sclerosis Center

Hadassah’s Prof. Karussis Will Chair International Neuroimmunology Conference

ALS Research

Stem Cell Treatment Inhibits ALS Disease Progression In 87% of Patients, according to clinical trial conducted by HMO and BrainStorm Cell Therapeutics

MS Research

Hadassah Conducts Unprecedented Trial of Stem Cell Treatment for MS

MS Research

Hadassah Center for Multiple Sclerosis Holds its Annual Conference

ALS Research

Hadassah International

Hadassah and Neurogenesis Announce Groundbreaking Results From Phase 2 MS Study

This World MS Day You Can Support the Outstanding MS Research at Hadassah

Student with MS Running the Jerusalem Marathon to Support Hadassah’s MS program

Mark Lewis to Discuss His MS Treatment at Hadassah on January 24, 2018

British Patient Talks To The BBC About Searching For A Miracle Cure For MS At Hadassah

Hadassah MS Patient Runs in the Jerusalem Marathon

Malia’s 18-year Odyssey with MS–and Back to Life As She Knew It

Hadassah Shares Breakthroughs at Annual World Stem Cell Summit

Being a Patient at Hadassah: Aly’s Blog

“Stunning Results” Continue with Hadassah’s Stem Cell Treatment to Reverse MS

Hadassah’s Prof. Karussis Will Chair International Neuroimmunology Conference

Stem Cell Treatment Inhibits ALS Disease Progression In 87% of Patients, according to clinical trial conducted by HMO and BrainStorm Cell Therapeutics

Hadassah Conducts Unprecedented Trial of Stem Cell Treatment for MS

Hadassah Center for Multiple Sclerosis Holds its Annual Conference

Hadassah’s Multiple Sclerosis Center: A Global Leader in Treating MS with Stem Cells